Evaluation of candidate vaccine approaches for MERS-CoV. - Wikidata - awgldk - TriplyDB

Evaluation of candidate vaccine approaches for MERS-CoV.

Evaluation of candidate vaccine approaches for MERS-CoV.

http://www.wikidata.org/entity/Q35917397

about

Development of Medical Countermeasures to Middle East Respiratory Syndrome Coronavirus Structure-Based Design of Head-Only Fusion Glycoprotein Immunogens for Respiratory Syncytial Virus Molecular aspects of MERS-CoV.MERS-CoV spike protein: a key target for antivirals.Epitope-Based Vaccine Target Screening against Highly Pathogenic MERS-CoV: An In Silico Approach Applied to Emerging Infectious Diseases.DNA vaccine encoding Middle East respiratory syndrome coronavirus S1 protein induces protective immune responses in mice.A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains Rapid development of a DNA vaccine for Zika virus Junctional and allele-specific residues are critical for MERS-CoV neutralization by an exceptionally potent germline-like antibody.Characterization and Demonstration of the Value of a Lethal Mouse Model of Middle East Respiratory Syndrome Coronavirus Infection and Disease Treatment strategies for Middle East respiratory syndrome coronavirus.3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3/2012 Toward Developing a Preventive MERS-CoV Vaccine-Report from a Workshop Organized by the Saudi Arabia Ministry of Health and the International Vaccine Institute, Riyadh, Saudi Arabia, November 14-15, 2015.Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.One-Health: a Safe, Efficient, Dual-Use Vaccine for Humans and Animals against Middle East Respiratory Syndrome Coronavirus and Rabies Virus.MERS-CoV virus-like particles produced in insect cells induce specific humoural and cellular imminity in rhesus macaques.Immunogenicity of Candidate MERS-CoV DNA Vaccines Based on the Spike Protein.Vaccines for Emerging Infectious Diseases: lessons from MERS coronavirus and Zika virus.Vaccines for the prevention against the threat of MERS-CoV.Middle East respiratory syndrome: current status and future prospects for vaccine development.Vaccines against Middle East respiratory syndrome coronavirus for humans and camels.Progress of Middle East respiratory syndrome coronavirus vaccines: a patent review.Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen.Middle East respiratory syndrome coronavirus: five years later.ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice.Chimpanzee adenoviral vectors as vaccines for outbreak pathogens.Adjuvants and the vaccine response to the DS-Cav1-stabilized fusion glycoprotein of respiratory syncytial virus.Strategies Using Bio-Layer Interferometry Biosensor Technology for Vaccine Research and Development.Development of Middle East Respiratory Syndrome Coronavirus vaccines - advances and challenges.Safety and tolerability of a novel, polyclonal human anti-MERS coronavirus antibody produced from transchromosomic cattle: a phase 1 randomised, double-blind, single-dose-escalation study.A roadmap for MERS-CoV research and product development: report from a World Health Organization consultation.MERS vaccines advance, but will humans or camels get the jab?Importance of neutralizing monoclonal antibodies targeting multiple antigenic sites on MERS-CoV Spike to avoid neutralization escape.MERS-CoV: Understanding the Latest Human Coronavirus Threat.Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus.Current understanding of middle east respiratory syndrome coronavirus infection in human and animal models

P2860

Q26700054-A77DCC86-3892-4B65-A539-E51E1EC79C38 Q27333522-8FABF604-0F3C-498E-BAFA-B2A8CA370F9F Q30234479-B15B24E0-AA69-446D-844F-F852863965FC Q30240139-3A26DDBA-CE5E-4C43-A0E9-C3809C2AA7BB Q30382230-4B0C4B61-ACC3-4BAC-A37C-170479FA4D2A Q30400066-037F9642-8767-47E6-8EB6-68C9373D92C1 Q30402347-06131336-5B1F-464D-861F-8891BD300F60 Q30845557-953D33E6-B899-4621-B1E0-32E9CFB34DDE Q34542032-C0B71788-E9FB-4715-8E00-FCF29EDECBEC Q36063562-12596AD9-D953-4654-819E-BD97785ACC88 Q36433987-235247E4-F20E-4B12-984B-697BA1C65590 Q36555622-14887018-1084-4D55-B6D2-8A741E9B64FB Q36626864-1FA8887A-5E62-48BC-85BA-3399932153E7 Q37169882-A0FB34D4-43B3-4121-BA50-E0DBA2FCD034 Q37512915-436951DA-D19D-4EF6-B507-7CF53CA0ACF5 Q37560824-ED805CA5-8FEA-4741-A7C0-EF9E9660F384 Q37706472-46FA57D7-31A2-47C7-9828-9086739EC5DF Q37717377-6F2E85D7-D3D4-4C36-BC3C-D3ECC21F07F2 Q38156536-FA330F93-9D4F-4664-9E69-D2F374663843 Q38778044-D850E37E-8EA0-4FF6-B26F-10C69EDDCC95 Q38959242-B20FBF71-AB5B-407F-8F35-86D305DE6085 Q38992327-9C99B739-7A03-4CB9-BFCA-92EDE3616E77 Q39102732-637951FC-B0C8-426D-920C-5F4F90D16AFF Q40083207-79D8D41D-6BF2-4407-BBD5-C09AC3412DE1 Q40085786-113DE6AF-F2D2-4F76-B01E-3CFC1C233987 Q40173497-DF7CD9EE-2159-4C81-87F8-02ADE6AD1B08 Q44106019-02600E2F-3263-4B1A-9896-56DE82AC73C7 Q45325639-28515E82-3D49-4B3E-A812-7C0173D85F94 Q47171892-0D889F00-2F78-4F75-B380-1A4FB4B0943C Q47607374-E883968E-3F07-46D7-892E-4AF61D663D3F Q47656792-2606376D-4864-4EC0-9338-93316BF953EB Q50793231-97251E61-6872-4294-9588-B10E5C7724AA Q50954130-FB14938E-AD9C-45E1-8C6C-0846A17FD9AE Q51149122-C54A1479-9C75-4F12-8E61-0C9DC90629AD Q53701486-60BEAE09-86A1-4925-AE80-36C9F36AD47C Q54241763-6448E5E5-768B-4EFD-98EB-1A5F820F072E Q56971688-ED48C7F9-3328-421E-9D67-D42306BCAD1D

P2860

Evaluation of candidate vaccine approaches for MERS-CoV.

http://www.wikidata.org/entity/Q35917397

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Evaluation of candidate vaccine approaches for MERS-CoV.

@ast

Evaluation of candidate vaccine approaches for MERS-CoV.

@en

type

label

Evaluation of candidate vaccine approaches for MERS-CoV.

@ast

Evaluation of candidate vaccine approaches for MERS-CoV.

@en

prefLabel

Evaluation of candidate vaccine approaches for MERS-CoV.

@ast

Evaluation of candidate vaccine approaches for MERS-CoV.

@en

P1433

Q35917397-6774D8DD-49FA-4E09-AB92-3E95AED59D94

P1476

Q35917397-FF602CB1-1832-409E-B82C-4380ABF40CF2

P2093

Q35917397-0307648F-48CA-4D84-ACF4-DAEF5BE13295

Q35917397-06BF72B3-B8B2-4955-AA0C-0107E5D41FE1

Q35917397-27A29156-30DB-4E6F-8CE0-2F3F0B3D2728

Q35917397-2BDC851F-0F76-4B9B-940E-919407A17B8E

Q35917397-40CA8FDF-D140-45B1-BBBE-FDF276E28D31

Q35917397-53803F03-4E4B-4F2A-990F-976A6A7B7E02

Q35917397-6C3C9D75-235D-4761-9E93-CF9C2E8C5F48

Q35917397-7B13A9F4-50CC-4190-AA88-B6F4CE63F8F4

Q35917397-862FB585-74DC-48E7-98C8-056D6CCEC3B6

Q35917397-888B1372-DBC8-44C0-85F9-ADA3BFDF1AEA

P2860

Q35917397-02D593DC-802F-4C83-91DF-1017D00BECB2

Q35917397-0A86B58F-DD41-4E6F-9354-F5D8802496E6

Q35917397-11B20265-45CB-48FA-9960-BED78AF3005F

Q35917397-12904269-B316-43F2-8507-0E94ADBA29E6

Q35917397-1B69CF5E-7B84-49D9-984C-BFFB1D270352

Q35917397-1F151EB4-107F-4240-92E1-5ADB46C5B0AC

Q35917397-2214D43B-53A9-4B48-8D09-E01708B9221C

Q35917397-237B85E2-96C7-4BC8-BC35-01F1C115E096

Q35917397-2D70EA59-9BC4-4E87-A3F4-917FCC78B8C1

Q35917397-378B4F9E-EEF1-4938-8CC8-03088EAC3705

P2888

Q35917397-8ABEEE7B-CA40-4E6D-B1C3-F26BD2AAD1EE

P304

Q35917397-1A62526A-839A-40FC-AEB2-824D2E149213

P31

Q35917397-FB7CC021-5595-423F-9D25-460DFFFEB84D

P356

Q35917397-5591E865-155D-4810-B440-CCE68EC781D0

P407

Q35917397-55C69838-A5B6-4EA3-B49D-CD24F79E2581

P478

Q35917397-82C3725A-67E3-4B31-91D2-7D6F1B37FE73

P50

Q35917397-299A233E-74F5-4D09-915C-FB5B8D3A1E54

Q35917397-3AF6840A-AE7B-449A-B8DB-2A072ECE8D06

Q35917397-3C6E8C08-F319-4021-8172-E44FC424A008

Q35917397-46F621CC-01CA-41DD-B9B5-E34C4A5D0C2A

Q35917397-5D013872-132A-4C84-8433-C55788A3754F

Q35917397-77DC384B-277A-40FB-A6D6-C1427CA24D23

Q35917397-7A238B34-3E95-4052-BEFA-CB0C145A85BA

Q35917397-A713A865-0C07-4E57-B44A-DFF3F984CD9B

Q35917397-ED5D12FA-4B54-40B4-9A14-219B403A98E5

P577

Q35917397-1EAEBE30-C1CF-4DEE-909A-2E971B8F8595

P5875

Q35917397-915FBA37-08EE-434F-9C5B-46807108038D

P698

Q35917397-E66CBE1B-0609-48BC-B8FD-32CA3772EB8B

P921

Q35917397-A80AB072-9DC3-4F9B-85CC-D495ACB9EF81

P932

Q35917397-7D9D2E3B-1BDA-4D63-9688-1EC2EE8DD50E

P356

P1433

Nature Communications

P1476

Evaluation of candidate vaccine approaches for MERS-CoV.

@en

P2093

Christopher R Lees

http://www.w3.org/2001/XMLSchema#string

Daniel J Mollura

http://www.w3.org/2001/XMLSchema#string

Gene Olinger

http://www.w3.org/2001/XMLSchema#string

Hadi M Yassine

http://www.w3.org/2001/XMLSchema#string

Jeffrey Solomon

http://www.w3.org/2001/XMLSchema#string

John P Todd

http://www.w3.org/2001/XMLSchema#string

Joshua C Johnson

http://www.w3.org/2001/XMLSchema#string

Kwanyee Leung

http://www.w3.org/2001/XMLSchema#string

Leatrice Vogel

http://www.w3.org/2001/XMLSchema#string

Lingshu Wang

http://www.w3.org/2001/XMLSchema#string

P2860

MolProbity: all-atom structure validation for macromolecular crystallography

PHENIX: a comprehensive Python-based system for macromolecular structure solution

Processing of X-ray diffraction data collected in oscillation mode

Three-dimensional structure of an Fv from a human IgM immunoglobulin

Structural insights into immune recognition of the severe acute respiratory syndrome coronavirus S protein receptor binding domain

Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody

Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus

Refinement of severely incomplete structures with maximum likelihood in BUSTER-TNT

Phasercrystallographic software

Features and development of Coot

P2888

P304

7712

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NCOMMS8712

http://www.w3.org/2001/XMLSchema#string

P407

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Peter B. Jahrling

Mark R. Denison

Kayvon Modjarrad

Barney S. Graham

P577

2015-07-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281456016

http://www.w3.org/2001/XMLSchema#string

P698

26218507

http://www.w3.org/2001/XMLSchema#string

P921

Middle East respiratory syndrome coronavirus

P932

4525294

http://www.w3.org/2001/XMLSchema#string